Priser
Platform
Blog
Om os
Download
NAVCO Pharmaceuticals
NAVCO Pharmaceuticals
TSX Venture Exchange
0

Om

Navco Pharmaceuticals Inc. operates as a company engaged in the research, development, and commercialization of pharmaceutical products. The primary function of Navco Pharmaceuticals is to produce innovative medications aimed at addressing a variety of health challenges and improving patient outcomes. This company focuses on developing therapeutics in key areas such as oncology, neurology, and infectious diseases, playing a crucial role in the healthcare and pharmaceutical industries. By engaging in cutting-edge research and development, Navco Pharmaceuticals contributes significantly to medical advancements and the availability of new treatment options. Its market significance is underscored by its potential to introduce drugs that may meet unmet medical needs, thereby impacting patient care and overall health infrastructure globally. Navco Pharmaceuticals collaborates with research institutions and healthcare providers to ensure that their products are both effective and accessible, further strengthening its position as a pivotal player in the pharmaceutical landscape.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I NAVCO PHARMACEUTICALS MED ENDAVU: Køb NAVCO Pharmaceuticals ($NAV) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i NAVCO Pharmaceuticals, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerNAV
Land
Canada
Hjemmesidenavcopharma.com
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk